The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Targeting the Motion of Shikimate Kinase: Development of Competitive Inhibitors that Stabilize an Inactive Open Conformation of the Enzyme.EBI
Universidade De Santiago De Compostela
Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.EBI
Universidade De Santiago De Compostela
1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.EBI
Universidade De Santiago De Compostela
Siderophores: Chemical tools for precise antibiotic delivery.EBI
Universidade De Santiago De Compostela
Potent and Subtype-Selective Dopamine DEBI
Universidade De Santiago De Compostela
Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme.EBI
Universidade De Santiago De Compostela
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective AEBI
Universidade De Santiago De Compostela
Exploring Non-orthosteric Interactions with a Series of Potent and Selective AEBI
Universidade De Santiago De Compostela
3,4-Dihydropyrimidin-2(1EBI
Universidade De Santiago De Compostela
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.EBI
Universidade De Santiago De Compostela
Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.EBI
Universidade De Santiago De Compostela
Antagonists of prostaglandin EP3 receptorBDB
Pfizer